(Q44120358)

30 November 2017

title

Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain (English)

1 reference

30 November 2017

1 reference

1

1 reference

30 November 2017

2

1 reference

30 November 2017

Gemma Parramon

3

1 reference

30 November 2017

J M Goikolea

series ordinal

4

1 reference

30 November 2017

Antonio Fernández

series ordinal

5

1 reference

30 November 2017

Antoni Benabarre

series ordinal

6

1 reference

30 November 2017

language of work or name

1 reference

1 October 2002

1 reference

Journal of Affective Disorders

30 November 2017

published in

1 reference

30 November 2017

volume

72

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

15-19

1 reference

Induction of mania by risperidone resistant to mood stabilizers

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

Clinical Factors in Lithium Carbonate Prophylaxis Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

Long-term risperidone treatment in bipolar disorder: 6-month follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

Acute treatment of bipolar disorder with adjunctive risperidone in outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

Treatment of Refractory Rapid Cycling Bipolar Disorder With Risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900481-5

7 January 2021

10.1016/S0165-0327(01)00481-5

Identifiers

DOI

1 reference

30 November 2017

1 reference